Godavari Biorefineries wins cancer treatment patent in Japan

Godavari Biorefineries wins cancer treatment patent in Japan. The Japanese Patent Office granted a patent for '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER'. This strengthens GBRL’s global IP portfolio and validates its R&D focus in oncology. Clinical and commercial success could drive future revenue streams.

📊 STOCKS: GBRL | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Patent